Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Corporate Governance Structure

Company Overview

Company Overview
Type Announcement
Representative Jae-chun Yoon , Seung-kook Park
Established on November 20th 1973
Listed on December 18th 1989 (listed on the securities market of the stock exchange)
Largest Shareholder Daewoong Pharmaceutical Co., Ltd.
Capital 26.1 billion KRW
Nominal Value 500 KRW
Total Issued Stocks 52,240,638
Number of Employees 389

Board of Directors

Board of Directors
Type Position Name Term Background Remarks
Executive Directors CEO Jae-chun Yoon 3 years CEO of Daewoong Co., Ltd.
CEO Seung-kook Park 3 years Chief Director of Bio Research Center of Daewoong Pharmaceutical Co., Ltd.
Executive Director Jong-wook Lee 3 years CEO of Daewoong Pharmaceutical Co., Ltd. Chairman of the Board of Directors
Executive Director Sung-wuk Kim 3 years CEO of Hanall Bio Pharma Co., Ltd.
Executive Director Bong-yong Lee 3 years Chief Director of R&D Division of Daewoong Pharmaceutical Co., Ltd.
Non-executive Directors Non-executive Directors Seong-jong Jo 3 years tax accountant at Jo Seong-jong Accounting Firm non-executive director and auditor
Non-executive Director Jin-hyeong Kim 3 years Samdo Accounting Firm Partner non-executive director and auditor
Non-executive Director Sung-sub Kim 3 years Director of Chungnam National Univ. Graduate School of Drug Development and Discovery Non-executive Directors and auditor